MiMedx Group (NASDAQ:MDXG – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
MiMedx Group (NASDAQ:MDXG – Get Free Report) last posted its quarterly earnings data on Tuesday, April 30th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. The business had revenue of $84.71 million during the quarter, compared to analysts’ expectations of $79.36 million. MiMedx Group had a return on equity of 39.42% and a net margin of 18.63%. On average, analysts expect MiMedx Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
MiMedx Group Stock Performance
MDXG opened at $7.62 on Tuesday. MiMedx Group has a 12-month low of $5.57 and a 12-month high of $9.27. The firm has a market capitalization of $1.12 billion, a P/E ratio of 17.32 and a beta of 1.99. The stock’s 50 day moving average price is $7.15 and its two-hundred day moving average price is $7.46. The company has a quick ratio of 2.71, a current ratio of 3.29 and a debt-to-equity ratio of 0.12.
Analysts Set New Price Targets
View Our Latest Report on MiMedx Group
MiMedx Group Company Profile
MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.
Featured Stories
- Five stocks we like better than MiMedx Group
- CD Calculator: Certificate of Deposit Calculator
- Why This Manufacturer is Committing to a Massive Buyback Program
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Healthcare Stock Rides the Acute Services Phenomenon to New Highs
Receive News & Ratings for MiMedx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group and related companies with MarketBeat.com's FREE daily email newsletter.